Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma

References

• Liver Cancer Study Group of J. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211(3):277–287.2155591
   PubMed Web of Science ®Google Scholar
• Pawlik TM. Biliary tract and primary liver tumors. Surg Oncol Clin N Am. 2014;23(2):xv–xvi. doi:10.1016/j.soc.2013.11.005
   PubMedGoogle Scholar
• Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol. 2006;45(6):856–867. doi:10.1016/j.jhep.2006.09.00117030071
   PubMed Web of Science ®Google Scholar
• Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98(12):873–875. doi:10.1093/jnci/djj23416788161
   PubMedGoogle Scholar
• Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84–96. doi:10.1097/SLA.0b013e318176c4d318580211
   PubMed Web of Science ®Google Scholar
• Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):115–125. doi:10.1055/s-2004-82888915192785
   PubMed Web of Science ®Google Scholar
• Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149(6):565–574. doi:10.1001/jamasurg.2013.513724718873
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–1195. doi:10.1200/JCO.2012.41.598423358969
   PubMed Web of Science ®Google Scholar
• de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140–3145. doi:10.1200/JCO.2011.35.651921730269
   PubMed Web of Science ®Google Scholar
• Antwi SO, Mousa OY, Patel T. Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995–2014. Ann Hepatol. 2018;17(2):274–285. doi:10.5604/01.3001.0010.865929469047
   PubMed Web of Science ®Google Scholar
• Wang M, Gao Y, Feng H, et al. A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Cancer Med. 2018;7(3):646–654. doi:10.1002/cam4.134129473340
   PubMed Web of Science ®Google Scholar
• Yeh CN, Wang SY, Chen YY, et al. A prognostic nomogram for overall survival of patients after hepatectomy for intrahepatic cholangiocarcinoma. Anticancer Res. 2016;36(8):4249–4258.27466540
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.2138828094848
   PubMed Web of Science ®Google Scholar
• Kamarajah SK. Evaluation of the AJCC 8th edition staging system for pathologically versus clinically staged intrahepatic cholangiocarcinoma (icca): a time to revisit a dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis. J Gastrointest Cancer. 2018. doi:10.1007/s12029-018-0084-5
   Web of Science ®Google Scholar
• Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52. doi:10.21037/cco30180751
   PubMed Web of Science ®Google Scholar
• Chinchilla-Lopez P, Aguilar-Olivos NE, Garcia-Gomez J, et al. Prevalence, risk factors, and survival of patients with intrahepatic cholangiocarcinoma. Ann Hepatol. 2017;16(4):565–568. doi:10.5604/01.3001.0010.0293
   PubMed Web of Science ®Google Scholar
• Kim Y, Moris DP, Zhang XF, et al. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol. 2017;116(6):643–650. doi:10.1002/jso.2472028608424
   PubMed Web of Science ®Google Scholar
• Kattan MW. Nomograms. Introduction. Semin Urol Oncol. 2002;20(2):79–81.12030248
   PubMedGoogle Scholar
• Pintilie M. Analysing and interpreting competing risk data. Stat Med. 2007;26(6):1360–1367. doi:10.1002/sim.265516900575
   PubMed Web of Science ®Google Scholar
• Zhang Z, Geskus RB, Kattan MW, Zhang H, Liu T. Nomogram for survival analysis in the presence of competing risks. Ann Transl Med. 2017;5(20):403. doi:10.21037/atm.2017.07.2729152503
   PubMed Web of Science ®Google Scholar
• Carmona R, Zakeri K, Green G, et al. Improved method to stratify elderly patients with cancer at risk for competing events. J Clin Oncol. 2016;34(11):1270–1277. doi:10.1200/JCO.2015.65.073926884579
   PubMed Web of Science ®Google Scholar
• Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244–256. doi:10.1093/aje/kwp10719494242
   PubMed Web of Science ®Google Scholar
• Gupta A, Dixon E. Epidemiology and risk factors: intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6(2):101–104. doi:10.21037/hbsn.2017.01.0228503557
   PubMed Web of Science ®Google Scholar
• McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1198–1203. doi:10.1158/1055-9965.EPI-05-081116775181
   PubMed Web of Science ®Google Scholar
• Eggener SE, Scardino PT, Walsh PC, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011;185(3):869–875. doi:10.1016/j.juro.2010.10.05721239008
   PubMed Web of Science ®Google Scholar
• Eguchi T, Bains S, Lee MC, et al. Impact of increasing age on cause-specific mortality and morbidity in patients with stage I Non-small-cell lung cancer: a competing risks analysis. J Clin Oncol. 2017;35(3):281–290. doi:10.1200/JCO.2016.69.083428095268
   PubMed Web of Science ®Google Scholar
• Farges O, Fuks D, Le Treut YP, et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer. 2011;117(10):2170–2177. doi:10.1002/cncr.2571221523730
   PubMed Web of Science ®Google Scholar
• Zhang CH, Li YY, Zhang QW, et al. The prognostic impact of the metastatic lymph nodes ratio in colorectal cancer. Front Oncol. 2018;8:628. doi:10.3389/fonc.2018.0062830619762
   PubMed Web of Science ®Google Scholar
• Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer. 2007;110(7):1532–1541. doi:10.1002/cncr.2293817702091
   PubMed Web of Science ®Google Scholar
• Schneider DF, Chen H, Sippel RS. Impact of lymph node ratio on survival in papillary thyroid cancer. Ann Surg Oncol. 2013;20(6):1906–1911. doi:10.1245/s10434-012-2802-823263904
   PubMed Web of Science ®Google Scholar
• Wen YS, Xi KX, Xi KX, et al. The number of resected lymph nodes is associated with the long-term survival outcome in patients with T2 N0 non-small cell lung cancer. Cancer Manag Res. 2018;10:6869–6877. doi:10.2147/CMAR.S18604730588092
   PubMedGoogle Scholar
• Nwogu CE, Groman A, Fahey D, et al. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Ann Thorac Surg. 2012;93(5):1614–1619; discussion 1619–1620. doi:10.1016/j.athoracsur.2012.01.065
   PubMed Web of Science ®Google Scholar
• Tamandl D, Kaczirek K, Gruenberger B, et al. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg. 2009;96(8):919–925. doi:10.1002/bjs.665419591163
   PubMed Web of Science ®Google Scholar
• Wang J, Dang P, Raut CP, et al. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg. 2012;255(3):478–485. doi:10.1097/SLA.0b013e31824857e222330040
   PubMed Web of Science ®Google Scholar
• Lee YC, Yang PJ, Zhong Y, Clancy TE, Lin MT, Wang J. Lymph node ratio-based staging system outperforms the Seventh AJCC System for Gastric Cancer: validation Analysis With National Taiwan University Hospital Cancer Registry. Am J Clin Oncol. 2017;40(1):35–41. doi:10.1097/COC.000000000000011025089533
   PubMed Web of Science ®Google Scholar
• Zhang J, Lv L, Ye Y, Jiang K, Shen Z, Wang S. Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer. J Cancer Res Clin Oncol. 2013;139(11):1947–1953. doi:10.1007/s00432-013-1525-y24057646
   PubMed Web of Science ®Google Scholar
• Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin. 2008;58(3):180–190. doi:10.3322/CA.2008.000118460593
   PubMed Web of Science ®Google Scholar
• Rochefort MM, Ankeny JS, Kadera BE, et al. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. Ann Surg Oncol. 2013;20(13):4322–4329. doi:10.1245/s10434-013-3159-323943022
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989X0629536117099194
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180. doi:10.1016/S1470-2045(14)71116-725846097
   PubMed Web of Science ®Google Scholar
• Wang ZX, Qiu MZ, Jiang YM, Zhou ZW, Li GX, Xu RH. Comparison of prognostic nomograms based on different nodal staging systems in patients with resected gastric cancer. J Cancer. 2017;8(6):950–958. doi:10.7150/jca.1737028529606
   PubMed Web of Science ®Google Scholar
• Hijazi Z, Oldgren J, Lindback J, et al. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet. 2016;387(10035):2302–2311. doi:10.1016/S0140-6736(16)00741-827056738
   PubMed Web of Science ®Google Scholar
• Dong F, Shen Y, Gao F, et al. Nomograms to predict individual prognosis of patients with primary small cell carcinoma of the bladder. J Cancer. 2018;9(7):1152–1164. doi:10.7150/jca.2334429675096
   PubMed Web of Science ®Google Scholar